Plexus (NASDAQ: PLXS) holder files to sell 5,000 shares

Rhea-AI Filing Summary

Plexus Corp. investor filed a Form 144 indicating an intent to sell 5,000 shares of common stock. The proposed sale is to be executed through Robert W. Baird & Co. on the NASDAQ, with an aggregate market value of $996,650 for the shares listed in the notice.

The table notes that 26,713,916 shares of Plexus common stock were outstanding, providing context for the planned sale. The 5,000 shares were originally acquired on 11/30/1999 in a transaction involving a Family Trust and David and Constance Foate, with the form listing an approximate sale date of 02/02/2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	ROBERT W BAIRD & CO. 777 E WISCONSIN AVE MILWAUKEE WI 53202	5000	996650	26713916	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/30/1999	Family Trust	David and Constance Foate			5000	11/30/1999	None

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the PLXS Form 144 filing disclose?

The Form 144 for Plexus Corp. discloses a planned sale of 5,000 common shares, with an aggregate market value of $996,650. The transaction is expected to be executed through Robert W. Baird & Co. on the NASDAQ exchange.

How many Plexus (PLXS) shares are planned to be sold?

The filing shows a proposed sale of 5,000 Plexus common shares. These shares are listed with an aggregate market value of $996,650, and the notice identifies NASDAQ as the exchange where the sale is expected to occur through Robert W. Baird & Co.

When were the PLXS shares to be sold originally acquired?

The 5,000 Plexus common shares were acquired on 11/30/1999. The form describes the acquisition as a Family Trust transaction from David and Constance Foate, with the same date listed for both acquisition and payment.

What is the approximate sale date in the Plexus Form 144?

The Form 144 lists an approximate sale date of 02/02/2026 for the 5,000 Plexus common shares. This planned transaction is to be carried out through Robert W. Baird & Co. on the NASDAQ exchange, subject to market conditions and applicable rules.

How many Plexus (PLXS) shares are shown as outstanding in the filing?

The Form 144 indicates that 26,713,916 Plexus common shares were outstanding. This figure provides context for the planned sale of 5,000 shares noted in the filing, helping readers understand the scale of the proposed transaction.

Which broker is named in the Plexus Form 144 filing?

The filing names Robert W. Baird & Co., located at 777 E Wisconsin Ave, Milwaukee, WI 53202, as the broker. This firm is listed to handle the proposed sale of 5,000 Plexus common shares on the NASDAQ exchange.